A RAPID PLATFORM TO GENERATE LIPOFUSCIN AND SCREEN THERAPEUTIC DRUGS FOR EFFICACY IN LIPOFUSCIN REMOVAL
Jason Gaspar, Jacques Mathieu, Pedro J. J. Alvarez
Pages: 1-9
Published: 9 Feb 2016
Views: 6,271
Downloads: 1,527
Abstract: Lipofuscin is a brown-yellow, autofluorescent polymeric material that accumulates in a ceroid manner within postmitotic cells during aging. Lipofuscin accumulation impairs proteosome and lysosome pathways critical to cell health and homeostasis. Therefore, the ability to quickly generate lipofuscin in vitro, and identify drugs that mitigate the accumulation or clear lipofuscin would be of great benefit to aging research. Here, we present a platform to quickly create lipofuscin-loaded (but otherwise healthy) cells and screen drugs for efficacy in lipofuscin removal. The combination of leupeptin, iron (III) chloride and hydrogen peroxide generates significant amounts of lipofuscin within cells while eliminating the need for a 40% hyperoxic chamber. Alternative methods which load fibroblasts with “artificial” lipofuscin obtained via UV-peroxidation of mitochondrial fragments are much more labor-intensive. This method is faster (≤10 days) than most protocols to generate lipofuscin and assess its removal, which typically require 2 to 4 weeks or longer to complete.
Keywords: lipofuscin, flow cytometry, fenton chemistry, autofluorescence, fluorescent microscopy
Cite this article: Jason Gaspar, Jacques Mathieu, Pedro J. J. Alvarez. A RAPID PLATFORM TO GENERATE LIPOFUSCIN AND SCREEN THERAPEUTIC DRUGS FOR EFFICACY IN LIPOFUSCIN REMOVAL. Journal of International Scientific Publications: Materials, Methods & Technologies 10, 1-9 (2016). https://www.scientific-publications.net/en/article/1001002/
© 2023 The Author(s). This is an open access article distributed under the terms of the
Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This permission does not cover any third party copyrighted material which may appear in the work requested.
Download full text
Back to the contents of the volume